|
|
|
42
|
2372X
|
XYLOMETAZOLINE 0.1% NASAL SP (FSB)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
10ML
|
A
|
2.42
|
2.42
|
BOTT
|
1
|
BOTT
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2026-04-01
|
2028-03-31
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
2026-03-05
|
|
|
|
40
|
23739
|
OTRIVINE 0.05% NASAL DR (GSK/COL) XYLOMETAZOL
|
XYLOMETAZOLINE
|
OTRIVINE
|
10ML
|
A
|
4.70
|
4.70
|
NASAL DROP
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
23739
|
OTRIVINE 0.05% NASAL DR (GSK) XYLOMETAZO (C)
|
XYLOMETAZOLINE
|
OTRIVINE
|
10ML
|
C
|
4.95
|
4.9473
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
42
|
23739
|
OTRIVINE 0.05% NASAL DR (GSK) XYLOMETAZO
|
XYLOMETAZOLINE
|
OTRIVINE
|
10ML
|
A
|
5.19
|
5.19
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
5232
|
EENT VASOCONSTRICTORS
|
2026-04-01
|
2028-03-31
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
41
|
2373E
|
XYLOMETAZOLINE 0.05% NASAL DR (KWA)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
15ML
|
A
|
2.61
|
2.6096
|
BOTT
|
1
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
40
|
2373G
|
OXOZOLIN PAED 0.025% NASAL DR (ARP/AHI) OXYME
|
OXYMETAZOLINE
|
OXOZOLIN PAED
|
10ML
|
A
|
4.05
|
4.05
|
NASAL DROP
|
1
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5232
|
EENT VASOCONSTRICTORS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
2373S
|
XYLOMETAZOLINE 0.05% NASAL DR (CIR/AHI)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
10ML
|
A
|
2.31
|
2.31
|
NASAL DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5232
|
EENT VASOCONSTRICTORS
|
2022-04-01
|
2022-09-30
|
|
NASAL
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-03-29
|
|
|
|
40
|
2392B
|
PMS-RISEDRONATE 35MG TAB (PMS/COL)
|
RISEDRONATE
|
PMS-RISEDRONATE
|
4'S
|
C
|
14.95
|
3.74
|
TABLET
|
0
|
TAB
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
2392B
|
PMS-RISEDRONATE 35MG TAB (PMS)
|
RISEDRONATE
|
PMS-RISEDRONATE
|
4'S
|
C
|
9.51
|
2.38
|
TAB
|
0
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
AVENTA BARBADOS
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
BONE RESORPTION INHIBITORS
|
|
|
|
|
41
|
2392C
|
APO-RISEDRONATE 35MG TAB (APO) (C)
|
RISEDRONATE
|
APO-RISEDRONATE
|
4'S
|
C
|
9.7
|
2.4261
|
TAB
|
0
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
BONE RESORPTION INHIBITORS
|
|
|
|
|
40
|
2401A
|
IDEW-FLO 1MG STRP (ENT/PHA) FLUORESCEIN
|
FLUORESCEIN
|
IDEW-FLO
|
100'S
|
B
|
20.12
|
20.12
|
STRIP
|
0
|
STRP
|
ENT
|
ENTOD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5236
|
EENT UNCLASSIFIED
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
2401A
|
IDEW-FLO 1MG STRP (ENT) FLUORESCEIN
|
FLUORESCEIN
|
IDEW-FLO
|
100'S
|
B
|
22.698
|
0.227
|
STRP
|
0
|
BOX
|
ENT
|
ENTOD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5236
|
EENT UNCLASSIFIED
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
EENT UNCLASSIFIED
|
|
|
|
|
42
|
2401AA
|
I-DEW FLO 1MG STRP (ENT) FLUORESCEIN
|
FLUORESCEIN
|
I-DEW FLO
|
100'S
|
B
|
19.71
|
0.20
|
STRP
|
0
|
N/A
|
ENT
|
ENTOD
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
3658
|
OCULAR DISORDERS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
OCULAR DISORDERS
|
|
|
|
|
40
|
24041
|
FLUORESCEIN MINIMS 1% EYE/EAR DR (CAM/STO)
|
FLUORESCEIN
|
FLUORESCEIN MINIMS
|
20X0.5ML
|
B
|
94.73
|
4.74
|
EYE/EAR DROP
|
0
|
AMP
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
STO
|
BRYDEN STOKES LTD
|
|
5236
|
EENT UNCLASSIFIED
|
2022-04-01
|
2024-03-31
|
|
Ophthalmic
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
24042
|
FLUORESCEIN MINIMS 1% EYE DR (CAM) (B)
|
FLUORESCEIN
|
FLUORESCEIN MINIMS
|
20X0.5ML
|
B
|
82.53
|
4.1264
|
BOX
|
0
|
AMPP
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5236
|
EENT UNCLASSIFIED
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT UNCLASSIFIED
|
|
|
|
|
40
|
2411B
|
HYPROMELLOSE 0.3% EYE DR (ASL/PHA)
|
HYPROMELLOSE
|
HYPROMELLOSE
|
10ML
|
A
|
3.75
|
3.75
|
EYE DROP
|
1
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5292
|
EENT DRUGS MISCELLANEOPUS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
2411B
|
HYPROMELLOSE 0.3% EYE DR (ASL)
|
HYPROMELLOSE
|
HYPROMELLOSE
|
10ML
|
A
|
7.64
|
7.6385
|
BOTT
|
1
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5292
|
EENT DRUGS MISCELLANEOPUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT DRUGS MISCELLANEOPUS
|
|
|
|
|
42
|
2411J
|
LACRYL SOOTHE 0.3% EYE DR (ABL) HYPROMELLOSE
|
HYPROMELLOSE
|
LACRYL SOOTHE
|
10ML
|
A
|
3.94
|
3.94
|
BOTT
|
1
|
BOTT
|
ABL
|
ABLE PHARMA
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5292
|
EENT DRUGS MISCELLANEOPUS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
6
|
EENT DRUGS MISCELLANEOPUS
|
|
|
|
|
40
|
2451AF
|
LOPERAMIDE 2MG CAP (CIP/AHI)
|
LOPERAMIDE
|
LOPERAMIDE
|
30X10
|
A
|
27.94
|
0.09
|
CAPSULE
|
30
|
CAP
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5608
|
ANTIDIARRHEA AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
40
|
2451AN
|
ALKA AD 2MG TAB (BSP/COL) LOPERAMIDE
|
LOPERAMIDE
|
ALKA AD
|
60'S
|
C
|
17.13
|
0.29
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
5608
|
ANTIDIARRHEA AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
GASTROINTESTINAL DRUGS
|
|
